Diabetes mellitus is the most common metabolic disease and its incidence is
increasing. New classifications have been recently proposed based upon a b
etter knowledge of pathogenesis, mechanisms of glucose transport and insuli
n resistance. The perioperative care of diabetic patients is less dependent
on blood-glucose control, which needs to be exceptionally tight, and is us
ually easily obtained thanks to pharmacological improvements, human insulin
s and analogues, technical progress with blood-glucose monitoring at the be
dside and infusion with constant flow rates. More important is the influenc
e of end-organ pathology, often clinically silent, which must be carefully
assessed during the preoperative evaluation. The organ impairments concern
especially the heart, but also all those organs that were modified by abnor
mal glycosylated proteins. The pre-existing pathology has many consequences
on anaesthesia management; the anaesthetic technique depends essentially o
n their existence. A better long-term control of diabetes both for Type 1 a
nd Type 2 by insulins, and the new oral anti-diabetic drugs reduce the inci
dence of the endorgan pathology and the risk linked to organ failures in th
e perioperative period.